BAGSVAERD, DENMARK--(Marketwire - February 03, 2012) -
Company Announcement no 8 2012: http://hugin.info/2013/R/1582573/494506.pdf
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Thomson Reuters ONE
[HUG#1582573]
Further information:
Media:
Anne Margrethe Hauge
Tel: (+45) 4442 3450
amhg@novonordisk.com
In North America:
Ken Inchausti
Tel: (+1) 609 514 8316
kiau@novonordisk.com
Investors:
Klaus Bulow Davidsen
Tel: (+45) 4442 3176
klda@novonordisk.com
Frank Daniel Mersebach
Tel: (+45) 4442 0604
fdni@novonordisk.com
Lars Borup Jacobsen
Tel: (+45) 3075 3479
lbpj@novonordisk.com
Jannick Lindegaard
Tel: (+1) 609 786 4575
jlis@novonordisk.com